Literature DB >> 22688668

Altered expression and signal transduction of endothelin-1 receptors in heritable and idiopathic pulmonary arterial hypertension.

Jun Yu1, Linda Taylor, Jamie Wilson, Suzy Comhair, Serpil Erzurum, Peter Polgar.   

Abstract

Human pulmonary arterial smooth muscle cells (PASMC) were isolated from elastic pulmonary arteries dissected from lungs of individuals with and without pulmonary arterial hypertension (PAH). Reflecting increased smooth muscle constriction in cells from PAH subject, Ca(2+) influx in response to endothelin-1 (ET-1) increased in all the PAH PASMC populations relative to the normal donor control cells. The ETA receptor mRNA levels remained unchanged, whereas the ETB receptor mRNA levels decreased in both heritable and idiopathic PAH-derived PASMC. All the PASMC populations expressed considerably higher ETA compared to ETB receptor number. Both ETA and ETB receptor numbers were reduced in bone morphogenetic protein receptor type II (BMPR2) mutation PAH. ETB receptors showed a particular reduction in number. Phospho-antibody array analysis of normal and BMPR2 deletion PASMC illustrated ERK and Akt activation to be the most prominent and to be taking place principally through ETB receptors in normal PASMC, but primarily through ETA receptors in PASMC from BMPR2 PAH subjects. Additionally in the PAH cells the total relative ET-1 signal response was markedly reduced. Western analysis from the BMPR2 PASMC duplicated the array results, whereas PASMC from iPAH subjects showed variability with most samples continuing to signal through ETB. In sum, these results indicate that generally both receptors are reduced in PAH particularly ETB, and that ETB signaling through protein kinases becomes markedly reduced in BMPR2 PASMC, while it continues in IPAH. Importantly, the data suggest that caution must be taken when applying ET-1 receptor antagonist therapy to PAH patients.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22688668      PMCID: PMC3496420          DOI: 10.1002/jcp.24132

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  21 in total

Review 1.  Structural basis of the function of endothelin receptor.

Authors:  T Masaki; H Ninomiya; A Sakamoto; Y Okamoto
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

Review 2.  Pulmonary arterial hypertension.

Authors:  Harrison W Farber; Joseph Loscalzo
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

3.  Human primary lung endothelial cells in culture.

Authors:  Suzy A A Comhair; Weiling Xu; Lori Mavrakis; Micheala A Aldred; Kewal Asosingh; Serpil C Erzurum
Journal:  Am J Respir Cell Mol Biol       Date:  2012-03-15       Impact factor: 6.914

4.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; M Yanagisawa; D Langleben; R P Michel; R Levy; H Shennib; S Kimura; T Masaki; W P Duguid; D J Stewart
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

5.  Human pulmonary circulation is an important site for both clearance and production of endothelin-1.

Authors:  J Dupuis; D J Stewart; P Cernacek; G Gosselin
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690

Review 6.  Cellular and molecular pathobiology of pulmonary arterial hypertension.

Authors:  Marc Humbert; Nicholas W Morrell; Stephen L Archer; Kurt R Stenmark; Margaret R MacLean; Irene M Lang; Brian W Christman; E Kenneth Weir; Oliver Eickelberg; Norbert F Voelkel; Marlene Rabinovitch
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

7.  Motif mutation of bradykinin B2 receptor second intracellular loop and proximal C terminus is critical for signal transduction, internalization, and resensitization.

Authors:  G N Prado; D F Mierke; M Pellegrini; L Taylor; P Polgar
Journal:  J Biol Chem       Date:  1998-12-11       Impact factor: 5.157

8.  Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure.

Authors:  R J Cody; G J Haas; P F Binkley; Q Capers; R Kelley
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

9.  Regulation of inducible bradykinin B1 receptor gene expression through absence of internalization and resensitization.

Authors:  X Zhou; G N Prado; L Taylor; X Yang; P Polgar
Journal:  J Cell Biochem       Date:  2000-06-06       Impact factor: 4.429

10.  Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia.

Authors:  Pascal de Lagausie; Anthony de Buys-Roessingh; Latifa Ferkdadji; Julien Saada; Sophie Aisenfisz; Christine Martinez-Vinson; Xavier Fund; Jean Michel Cayuela; Michel Peuchmaur; Jean Christophe Mercier; Dominique Berrebi
Journal:  J Pathol       Date:  2005-01       Impact factor: 7.996

View more
  12 in total

1.  DNA microarray and signal transduction analysis in pulmonary artery smooth muscle cells from heritable and idiopathic pulmonary arterial hypertension subjects.

Authors:  Jun Yu; Jamie Wilson; Linda Taylor; Peter Polgar
Journal:  J Cell Biochem       Date:  2015-03       Impact factor: 4.429

2.  BDNF secretion by human pulmonary artery endothelial cells in response to hypoxia.

Authors:  Martin Helan; Bharathi Aravamudan; William R Hartman; Michael A Thompson; Bruce D Johnson; Christina M Pabelick; Y S Prakash
Journal:  J Mol Cell Cardiol       Date:  2014-01-23       Impact factor: 5.000

3.  Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension.

Authors:  Natasha M Rogers; Mingyi Yao; John Sembrat; M Patricia George; Heather Knupp; Mark Ross; Maryam Sharifi-Sanjani; Jadranka Milosevic; Claudette St Croix; Revathi Rajkumar; Maria G Frid; Kendall S Hunter; Luciano Mazzaro; Enrico M Novelli; Kurt R Stenmark; Mark T Gladwin; Ferhaan Ahmad; Hunter C Champion; Jeffrey S Isenberg
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

Review 4.  Perioperative pharmacological management of pulmonary hypertensive crisis during congenital heart surgery.

Authors:  Nathan Brunner; Vinicio A de Jesus Perez; Alice Richter; François Haddad; André Denault; Vanessa Rojas; Ke Yuan; Mark Orcholski; Xiaobo Liao
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

5.  Hyperplastic Growth of Pulmonary Artery Smooth Muscle Cells from Subjects with Pulmonary Arterial Hypertension Is Activated through JNK and p38 MAPK.

Authors:  Jamie L Wilson; Jun Yu; Linda Taylor; Peter Polgar
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

6.  A cell permeable peptide targeting the intracellular loop 2 of endothelin B receptor reduces pulmonary hypertension in a hypoxic rat model.

Authors:  Daniel S Green; Chamila Rupasinghe; Rod Warburton; Jamie L Wilson; Christine O Sallum; Linda Taylor; Achani Yatawara; Dale Mierke; Peter Polgar; Nicholas Hill
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

7.  Complex inheritance in Pulmonary Arterial Hypertension patients with several mutations.

Authors:  Guillermo Pousada; Adolfo Baloira; Diana Valverde
Journal:  Sci Rep       Date:  2016-09-15       Impact factor: 4.379

8.  Participation of PLK1 and FOXM1 in the hyperplastic proliferation of pulmonary artery smooth muscle cells in pulmonary arterial hypertension.

Authors:  Jamie L Wilson; Lizhen Wang; Zeyu Zhang; Nicholas S Hill; Peter Polgar
Journal:  PLoS One       Date:  2019-08-22       Impact factor: 3.240

9.  Unraveling endothelin-1 induced hypercontractility of human pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension.

Authors:  Jamie L Wilson; Rod Warburton; Linda Taylor; Deniz Toksoz; Nicholas Hill; Peter Polgar
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

Review 10.  Subchondral bone proteomics in osteoarthritis: Current status and perspectives.

Authors:  Pok Man Boris Chan; Lin Zhu; Chun Yi Wen; Kwong Yuen Chiu
Journal:  J Orthop Translat       Date:  2015-03-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.